About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 3

PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders

Pharmacokinetics of Sofosbuvir and Ledipasvir in Hepatitis C Virus - Infected Adolescent Patients With Haematological Disorders

NCT04353986•Ain Shams University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HCV InfectionBeta Thalassemia Major

Interventions

Sofosbuvir and Ledipasvir

Locations

1

Egypt

Locations (1)

Masri-Crc

Cairo, Egypt

Key Dates

Start Date

June 11, 2018

Primary Completion Date

April 1, 2023

Completion Date

December 1, 2023

Last Updated

March 6, 2023

Related Studies

Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

NCT06928259

Inspiratory Muscle Training in Children With Beta Thalasemia

NCT06466304

Beta Thalassemia Major

Active Not RecruitingNA

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

NCT05992077

Active Not RecruitingNA

APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies

NCT05534633

HIV InfectionsHCV Infection+1 more

Not Yet Recruiting

"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"

NCT07412977

HIV InfectionHBV Infection+3 more

Not Yet Recruiting

Hepatitis B and C Within the Chinese Community in Milan

NCT07241962

HBV (Hepatitis B Virus)HCV Infection

View all related studies

Contacts

Manal H El-Sayed, M.D.

CONTACT

01227461120 manalhelsayed@yahoo.co.uk

Fatma S Ebeid, M.D.

CONTACT

01095569596 dr.fatma_ebeid@yahoo.com

Sponsors

Lead Sponsor

Ain Shams University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions